These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 21771130)

  • 1. How prompt is prompt in daily practice? Earlier initiation of empirical antibacterial therapy for the febrile neutropenic patient.
    van Vliet M; Potting CM; Sturm PD; Donnelly JP; Blijlevens NM
    Eur J Cancer Care (Engl); 2011 Sep; 20(5):679-85. PubMed ID: 21771130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Application of the concepts of evidence-based medicine to the evidence on the treatment of febrile neutropenia].
    Jarque I; Sanz MA
    Enferm Infecc Microbiol Clin; 1999; 17 Suppl 2():95-102. PubMed ID: 10605194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementation of an evidence-based order set to impact initial antibiotic time intervals in adult febrile neutropenia.
    Best JT; Frith K; Anderson F; Rapp CG; Rioux L; Ciccarello C
    Oncol Nurs Forum; 2011 Nov; 38(6):661-8. PubMed ID: 22037329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementation of risk stratified antibiotic therapy for neutropenic fever: what are the risks?
    Wierema J; Konecny P; Links M
    Intern Med J; 2013 Oct; 43(10):1116-24. PubMed ID: 23869563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Admission and care of the febrile neutropenic patient in a community hospital setting.
    Ford MS; Helsley M
    J Support Oncol; 2005; 3(6 Suppl 4):22-3. PubMed ID: 16355555
    [No Abstract]   [Full Text] [Related]  

  • 6. Empirical and subsequent use of antibacterial agents in the febrile neutropenic patient.
    De Pauw BE; Raemaekers JM; Schattenberg T; Donnelly JP
    J Intern Med Suppl; 1997; 740():69-77. PubMed ID: 9350186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perspectives for the management of febrile neutropenic patients with cancer in the 21st century.
    Sipsas NV; Bodey GP; Kontoyiannis DP
    Cancer; 2005 Mar; 103(6):1103-13. PubMed ID: 15666328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Empirical antibiotic therapy for febrile neutropenia].
    Kridel R; Van Delden C; Calandra T; Marchetti O
    Rev Med Suisse; 2008 Apr; 4(152):914, 916-9. PubMed ID: 18578432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy.
    Freifeld A; Marchigiani D; Walsh T; Chanock S; Lewis L; Hiemenz J; Hiemenz S; Hicks JE; Gill V; Steinberg SM; Pizzo PA
    N Engl J Med; 1999 Jul; 341(5):305-11. PubMed ID: 10423464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ciprofloxacin and amoxicillin as continuation treatment of febrile neutropenia in pediatric cancer patients.
    Park JR; Coughlin J; Hawkins D; Friedman DL; Burns JL; Pendergrass T
    Med Pediatr Oncol; 2003 Feb; 40(2):93-8. PubMed ID: 12461792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Empirical antibiotic therapy in febrile neutropenic patients with acute leukemia].
    Yabe H; Nakamura F; Ishikawa T; Nagai K; Nakayama S
    Rinsho Ketsueki; 1989 May; 30(5):644-9. PubMed ID: 2795878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutropenic fever: one institution's quality improvement project to decrease time from patient arrival to initiation of antibiotic therapy.
    Baltic T; Schlosser E; Bedell MK
    Clin J Oncol Nurs; 2002; 6(6):337-40. PubMed ID: 12434465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compliance with a critical pathway for the management of febrile neutropenia and impact on clinical outcomes.
    Zuckermann J; Moreira LB; Stoll P; Moreira LM; Kuchenbecker RS; Polanczyk CA
    Ann Hematol; 2008 Feb; 87(2):139-45. PubMed ID: 17938926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cefepime plus amikacin as an initial empirical therapy of febrile neutropenia in paediatric cancer patients.
    Hamidah A; Lim YS; Zulkifli SZ; Zarina AL; Nordiah AJ; Jamal R
    Singapore Med J; 2007 Jul; 48(7):615-9. PubMed ID: 17609821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotics in 30 minutes or less for febrile neutropenic patients: a quality control measure in a new hospital.
    Corey AL; Snyder S
    J Pediatr Oncol Nurs; 2008; 25(4):208-12. PubMed ID: 18539908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Audit of once-daily dosing gentamicin therapy in neutropenic fever.
    Cooke RP; Grace RJ; Gover PA
    Int J Clin Pract; 1997 Jun; 51(4):229-31. PubMed ID: 9287264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics and therapeutic outcome of patients with febrile neutropenia who present in shock: need for better strategies.
    Malik I; Hussain M; Yousuf H
    J Infect; 2001 Feb; 42(2):120-5. PubMed ID: 11531318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Febrile neutropenia in haematological malignancies.
    Sharma A; Lokeshwar N
    J Postgrad Med; 2005; 51 Suppl 1():S42-8. PubMed ID: 16519255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized comparison of antibiotics with and without granulocyte colony-stimulating factor in children with chemotherapy-induced febrile neutropenia: a report from the Children's Oncology Group.
    Ozkaynak MF; Krailo M; Chen Z; Feusner J
    Pediatr Blood Cancer; 2005 Sep; 45(3):274-80. PubMed ID: 15806544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Value of mono-antibiotic therapy using piperacillin associated with sulbactam and possibly followed by vancomycin in febrile neutropenia in solid tumors].
    Abs L; Kattan J; Culine S; Bekradda M; Farhat F; Droz JP
    Bull Cancer; 1994 Oct; 81(10):871-6. PubMed ID: 7734770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.